spot_img
Saturday, January 28, 2023
spot_img

Cuatrecasas assists Axon with the creation of €150m PE fund

Cuatrecasas has advised the fund manager Axon Partners Group on the creation of the Private Equity fund Isetec V FCR

-

The fund will have a size of €150 million and will focus on innovative companies listed on European alternative stock markets, which offer great opportunities in small caps in the technology sector. The name of the fund, ISETEC V FCR, stands for Inversiones Significativas en Empresas Tecnológicas Cotizadas (Significant Investments in Listed Technology Companies).

With this deal, Axon Partners Group aims to create a new line of investment that operates between venture capital and value funds, thus achieving a balance between profitability, risk and liquidity. The fund manager has high expectations for this fund, especially given the good dynamics and performance of the European smaller companies sector in recent times.

“We have been working on this concept for several years and we believe that given Axon’s experience and the market opportunity, now is the perfect time to launch it in a decisive way. With Isetec we intend to create a new line of investment whose positioning is somewhere between venture capital and value funds, so it achieves a very good balance between profitability, risk and liquidity,” said Francisco Velázquez, managing partner at Axon.

Cuatrecasas advised Axon Partners Group with a team made up of Finance & Funds partner Jorge Canta, Tax partner Paz Irazusta and Corporate associate Ana Serrano.

- Advertisement -spot_img
- Advertisement -spot_img

MOST READ NEWS

Jones Day announces new Corporate leadership

As practice leaders, they will coordinate and oversee the firm's transactional work worldwide, including both the firm's M&A and Private Equity subpractices. These appointments,...

Linklaters advises on first high yield transaction in Europe in 2023

Tereos is a leading global agro-industrial cooperative specialising in the sourcing and processing of agricultural raw materials. The company is present in 127 countries...

Linklaters advises IVIRMA on its €3bn sale to KKR

The US fund has signed the acquisition of the Spanish company, a world leader in infertility treatments, eleven months after the transaction was announced,...
spot_img
spot_img
spot_img
spot_img
- Advertisement -spot_img
- Advertisement -spot_img
- Advertisement -spot_img
error: